Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,713 | 120 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $993.98 | 22 | $0 (2024) |
| Amgen Inc. | $542.65 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $508.84 | 16 | $0 (2023) |
| Lilly USA, LLC | $240.63 | 8 | $0 (2022) |
| PFIZER INC. | $185.58 | 16 | $0 (2020) |
| Horizon Pharma plc | $145.23 | 2 | $0 (2018) |
| Integra LifeSciences Corporation | $133.52 | 1 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $131.48 | 3 | $0 (2017) |
| Gilead Sciences, Inc. | $125.12 | 5 | $0 (2022) |
| Iroko Pharmaceuticals, LLC | $106.48 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.84 | 9 | GlaxoSmithKline, LLC. ($193.32) |
| 2023 | $576.79 | 14 | GlaxoSmithKline, LLC. ($374.47) |
| 2022 | $454.68 | 15 | GlaxoSmithKline, LLC. ($218.46) |
| 2021 | $810.07 | 21 | Amgen Inc. ($321.04) |
| 2020 | $384.19 | 19 | Amgen Inc. ($87.59) |
| 2019 | $266.98 | 4 | Integra LifeSciences Corporation ($133.52) |
| 2018 | $334.80 | 15 | Horizon Pharma plc ($145.23) |
| 2017 | $613.71 | 24 | AstraZeneca Pharmaceuticals LP ($284.58) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 06/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 05/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $114.42 | General |
| Category: RESPIRATORY | ||||||
| 03/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 03/30/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $122.73 | General |
| 02/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $114.17 | General |
| Category: Cardiology | ||||||
| 11/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 477 | 991 | $93,635 | $50,367 |
| 2022 | 13 | 554 | 1,027 | $93,370 | $56,619 |
| 2021 | 13 | 498 | 1,040 | $94,005 | $56,085 |
| 2020 | 11 | 520 | 1,053 | $101,785 | $51,932 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 433 | $58,455 | $28,969 | 49.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $12,690 | $11,271 | 88.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 170 | $16,150 | $8,051 | 49.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 57 | $2,850 | $785.70 | 27.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 11 | 11 | $440.00 | $348.92 | 79.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $330.00 | $315.48 | 95.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 47 | 87 | $870.00 | $191.40 | 22.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 16 | $800.00 | $158.85 | 19.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 16 | $480.00 | $155.70 | 32.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 78 | $390.00 | $61.58 | 15.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 14 | 18 | $180.00 | $57.78 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 457 | $57,135 | $32,813 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 193 | $16,415 | $9,641 | 58.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 77 | 77 | $10,395 | $9,449 | 90.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $2,535 | $2,048 | 80.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 23 | 62 | $2,480 | $740.62 | 29.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 24 | 25 | $750.00 | $406.97 | 54.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 13 | $390.00 | $353.92 | 90.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 11 | 11 | $440.00 | $346.24 | 78.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 17 | 17 | $435.00 | $277.55 | 63.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 49 | 106 | $1,060 | $232.46 | 21.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 21 | $945.00 | $190.86 | 20.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 14 | 14 | $210.00 | $60.81 | 29.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 18 | 18 | $180.00 | $58.18 | 32.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 176 | 522 | $65,250 | $38,075 | 58.4% |
About Dr. Trung Pham, D.O
Dr. Trung Pham, D.O is a Emergency Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700851052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Trung Pham, D.O has received a total of $3,718 in payments from pharmaceutical and medical device companies, with $276.84 received in 2024. These payments were reported across 121 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,713).
As a Medicare-enrolled provider, Pham has provided services to 2,049 Medicare beneficiaries, totaling 4,111 services with total Medicare billing of $215,003. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Tulsa, OK
- Active Since 02/21/2006
- Last Updated 10/18/2013
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700851052
Products in Payments
- TRELEGY ELLIPTA (Drug) $617.04
- FARXIGA (Drug) $369.76
- AREXVY (Drug) $254.21
- Repatha (Biological) $246.23
- Aimovig (Biological) $169.43
- OMNIGRAFT (Device) $133.52
- UTIBRON (Drug) $131.48
- Otezla (Drug) $126.99
- BYDUREON (Drug) $125.22
- PRIMARY CARE - DISEASE STATE (Drug) $125.02
- EMGALITY (Drug) $122.19
- TRULICITY (Drug) $118.44
- VIVLODEX (Drug) $106.48
- NURTEC ODT (Drug) $103.80
- EUCRISA (Drug) $69.47
- JARDIANCE (Drug) $64.48
- CHANTIX (Drug) $59.63
- Cologuard Collection Kit (Device) $49.22
- REXULTI (Drug) $43.15
- HORIZANT (Drug) $39.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Tulsa
Darnell Blackmon, Md, MD
Emergency Medicine — Payments: $87,410
Dr. Jeffrey Goodloe, M.d, M.D
Emergency Medicine — Payments: $11,859
Jeffrey Johnson, Md, MD
Emergency Medicine — Payments: $5,156
William Gray, Md, MD
Emergency Medicine — Payments: $1,769
Dr. Patricia Ellison-Brown, Do, DO
Emergency Medicine — Payments: $1,507
Dr. Jeffrey Dixon, Md, MD
Emergency Medicine — Payments: $1,443